Answer
Medicines that inhibit or induce CYP enzymes are not expected to affect blood levels of nivolumab + relatlimab because these monoclonal antibodies are not metabolised by CYP enzymes, although no interaction studies have been conducted.
Sources for this answer
- Opdualag 240 mg/80 mg concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 6Document updated
Sources checked